Darum lohnt es sich
The Institute Well-established, high-performing diagnostic pathology provider with excellent market position 5–6 consultant pathologists currently in the group, supported by 1–2 residents Broad diagnostic scope with strong hospital linkage: Significant routine biopsies and a high volume of hospital-referred cases Coverage across all organ systems except: No hematopathology No gynecological cytology Non-gynecological cytology is part of the service Access to university-level molecular pathology capability (advanced diagnostics available) The Role Deliver high-quality diagnostic reporting across a broad general pathology workload Contribute to clinical discussions and collaboration with referring hospitals and clinicians Join the senior group as a Partner / Shareholder with 25% ownership (details shared under NDA) Opportunity to shape strategy, service development, and long-term succession planning Candidate Profile (Indicative) Board-certified pathologist Comfortable working across a broad general histopathology spectrum Interest in long-term partnership and ownership; commercially minded but quality-driven Experience with (or strong interest in) modern diagnostics including molecular pathology access pathways German language capability likely required for day-to-day clinical communication (level can be discussed) Compensation / Upside Very high income potential due to: Strong profitability of the institute High revenue split associated with the partner model Equity entry structure and financials to be disclosed in a confidential process Location NRW — commutable from the wider Ruhr region. #J-18808-Ljbffr Partner / Shareholder Pathologist (25% Equity) — North Rhine–Westphalia A highly profitable, established pathology institute in NRW is seeking an experienced Consultant Pathologist to join the group as a Partner / Shareholder , acquiring c. 25% of the institute as part of a structured succession / growth plan.
This is a rare chance to step into a senior, long-term leadership position with exceptionally strong earning potential , supported by a high revenue split and a stable, diversified case mix.
